英和和英

名詞

itacitinib (uncountable)

1. (pharmacology) An experimental medication belonging to the class of Janus kinase inhibitors.
   • 2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172:

     The JAK1-selective inhibitor, itacitinib, is currently being assessed in multiple clinical trials for oncologic indications as well as for chronic and acute GVHD, including GVHD prophylaxis.